Westside Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Westside Investment Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.3K	Buy	1,500 +500	+50%	+$3.88K	﹤0.01%	1010
2025 Q4	$7.8K	Buy	1,000 +500	+100%	+$3.62K	﹤0.01%	1150
2025 Q3	$3.79K	Hold	500	–	–	﹤0.01%	1289
2025 Q2	$4.48K	Hold	500	–	–	﹤0.01%	1159
2025 Q1	$3.75K	Hold	500	–	–	﹤0.01%	820
2024 Q4	$3.76K	Hold	500	–	–	﹤0.01%	814
2024 Q3	$3.8K	Hold	500	–	–	﹤0.01%	814
2024 Q2	$3.09K	Hold	500	–	–	﹤0.01%	832
2024 Q1	$2.54K	Hold	500	–	–	﹤0.01%	809
2023 Q4	$3K	Hold	500	–	–	﹤0.01%	760
2023 Q3	$3.54K	Hold	500	–	–	﹤0.01%	730
2023 Q2	$3.52K	Buy	+500	New	+$4.01K	﹤0.01%	737

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return